0000950170-24-097189.txt : 20240814 0000950170-24-097189.hdr.sgml : 20240814 20240814171028 ACCESSION NUMBER: 0000950170-24-097189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240812 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: John Minardo CENTRAL INDEX KEY: 0001875067 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 241209444 MAIL ADDRESS: STREET 1: 100 SUMMER STREET STREET 2: SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043404176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 4 1 ownership.xml 4 X0508 4 2024-08-12 0001446847 IRONWOOD PHARMACEUTICALS INC IRWD 0001875067 John Minardo C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 false true false false Chief Legal Officer false Class A Common Stock 2024-08-12 4 S false 9910 4.27 D 284661 D The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person. /s/ Brian Tessler, Attorney-in-Fact 2024-08-14